Ganguli M, Dodge HH, Shen C, Pandav RS, DeKosky ST
GLP-1 medications currently named in lawsuits and regulatory investigations include: Individuals who experienced hospitalization, emergency treatment, surgery, prolonged gastrointestinal symptoms, or medically documented vision loss after taking these medications may have grounds to pursue legal action
When independent organizations like Consumer Reports conduct testing, Transparent Labs products consistently perform at the top of safety rankings
Mar 2021;10(3):1401-1409
If you prefer guided care instead of self-experimenting, our Primary Concierge program provides medically supervised peptide therapy, personalized dosing, and ongoing clinical support